United Therapeutics Corporation ... injection to treat patients with pulmonary arterial hypertension (PAH) to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of ...

The PAH Initiative is hosting a video event in May to provide information about exercise benefits for PAH patients.

We recently published a list of 11 Best Quality Penny Stocks to Buy According to Hedge Funds. In this article, we are going ...

Merck MRK will report its first-quarter 2024 earnings on April 24, before market open. The Zacks Consensus Estimate for first ...

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- United Therapeutics Corporation (UTHR) announced today that it will report its first quarter 2025 financial results before the ...

Background: The use of appetite suppressants in Europe has been associated with the development of primary pulmonary hypertension ... became widely used in the United States but were withdrawn ...

United Therapeutics (UTHR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

TRYVIO (aprocitentan) in the US and JERAYGO in Europe present significant market potential as novel therapies for patients with hypertension ... into 7MM [the United States, the EU4 (Germany ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...